|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 237.68 USD | -1.49% |
|
-1.95% | +5.44% |
| 01-16 | Promising launch for Wegovy pill: Novo Nordisk shares surge in the US |  |
| 01-16 | Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | US$259.65 | +9.24% | 20 | ||||||
| CHF 677.74 | +21.2% | 23 | ||||||
| US$404.19 | +19.52% | 24 | ||||||
| ₩235,751.77 | +12.8% | 22 | ||||||
| US$91 | -24.34% | 19 | ||||||
| US$545.75 | -10.66% | 12 | ||||||
| €67.85 | -5.92% | 15 | ||||||
| US$205.69 | +12.64% | 16 | ||||||
| US$226.57 | +27.68% | 15 | ||||||
| US$87.92 | +25.01% | 12 | ||||||
| US$90.63 | +18.73% | 22 | ||||||
| US$209.64 | -4.58% | 14 | ||||||
| US$70 | +1.94% | 12 | ||||||
| US$52.83 | +11.07% | 13 | ||||||
| Average | 17,052.95 | +8.17% | 17 | ||||||
| Weighted average by Cap. | 25,004.86 | +9.64% | 19 |
- Stock Market
- Equities
- IQV Stock
- Sector Iqvia Holdings Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition